Note 9 - Segment Information

9 Months Ended

Mar. 31, 2014

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

Note 9. Segment Information

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into three reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the three months ended March 31, 2014 and 2013 were $2,113 and $3,040, respectively and for the nine months ended March 31, 2014 and 2013 were $8,369 and $9,353, respectively.

Financial information relating to the three months ended March 31, 2014 and 2013 operations by business segment are as follows:

		Sales, Net
		U.S.		International				Gross					Capital
		Customers		Customers		Total		Profit (Loss)			Depreciation		Expenditures
Contract Manufacturing	2014	$	4,713	$	2,058	$	6,771	$	643		$	57	$	86
	2013		4,505		2,997		7,502		1,145			54		60
Branded Proprietary Products	2014		147		45		192		(64	)		1		-
	2013		178		20		198		(14	)		1		-
Other Nutraceutical Businesses	2014		549		10		559		148			2		-
	2013		429		23		452		106			6		3
Total Company	2014		5,409		2,113		7,522		727			60		86
	2013		5,112		3,040		8,152		1,237			61		63

Financial information relating to the nine months ended March 31, 2014 and 2013 operations by business segment are as follows:

		Sales, Net						Segment
		U.S.		International				Gross				Capital
		Customers		Customers		Total		Profit		Depreciation		Expenditures
Contract Manufacturing	2014	$	15,115	$	7,739	$	22,854	$	3,217	$	185	$	166
	2013		12,934		7,878		20,812		3,082		198		68
Branded Proprietary Products	2014		409		527		936		100		2		-
	2013		467		1,356		1,823		529		6		-
Other Nutraceutical Businesses	2014		1,608		103		1,711		476		8		2
	2013		1,273		119		1,392		330		11		3
Total Company	2014		17,132		8,369		25,501		3,793		195		168
	2013		14,674		9,353		24,027		3,941		215		71

	Total Assets as of
	March 31,		June 30,
	2014		2013
Contract Manufacturing	$	6,669	$	8,524
Branded Proprietary Products		1,942		2,186
Other Nutraceutical Businesses		1,711		1,901
Total Company	$	10,322	$	12,611